Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/10/2014 | CN101868534B 用于鉴定、扩增和去除成体干细胞和癌干细胞的方法 For the identification, amplification and removal of adult stem cells and cancer stem cells |
12/10/2014 | CN101861164B 朊病毒蛋白相关疾病的治疗 Treatment of a disease associated prion protein |
12/10/2014 | CN101827936B Cdh3肽以及含有cdh3肽的药剂 Cdh3 peptides and peptide drug containing cdh3 |
12/10/2014 | CN101678078B Sparc及其使用方法 Sparc and methods of use |
12/09/2014 | US8909483 Direct or indirect diagnostic test for helminth infection |
12/09/2014 | US8907163 Transgenic plants expressing galactosyltransferase and sialyl transferase |
12/09/2014 | US8907078 Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field |
12/09/2014 | US8907071 Toxin peptide therapeutic agents |
12/09/2014 | US8907068 Anti-IL-20 antibodies and binding partners and methods of using in inflammation |
12/09/2014 | US8907066 Antibody fusion proteins with a modified FcRn binding site |
12/09/2014 | US8907064 Modified human four helical bundle polypeptides and their uses |
12/09/2014 | US8907060 Mutated Pseudomonas exotoxins with reduced antigenicity |
12/09/2014 | US8907057 Peptides that target dorsal root ganglion neurons |
12/09/2014 | US8907055 Mutant sox proteins and methods of inducing pluripotency |
12/09/2014 | US8907053 Immunosuppression modulating compounds |
12/09/2014 | US8906951 Use of NK-1 receptor antagonists in pruritus |
12/09/2014 | US8906929 Inhibitors of human immunodeficiency virus replication |
12/09/2014 | US8906926 Substituted diketopiperazine analogs for use as drug delivery agents |
12/09/2014 | US8906901 Administration of dipeptidyl peptidase inhibitors |
12/09/2014 | US8906897 Antimicrobial agents based on hemin derivatives |
12/09/2014 | US8906866 Antibiotic compositions for the treatment of gram negative infections |
12/09/2014 | US8906865 Treatment of inflammation and/or endotoxic shock |
12/09/2014 | US8906864 Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
12/09/2014 | US8906863 Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector |
12/09/2014 | US8906862 Multiple antigen delivery system using hepatitis E virus-like particle |
12/09/2014 | US8906861 Pharmaceutical compositions comprising cyclosporins |
12/09/2014 | US8906860 Methods and compositions inhibiting tumor cell proliferation |
12/09/2014 | US8906859 Uses of kappa opioid synthetic peptide amides |
12/09/2014 | US8906858 Method for the prophylactic or therapeutic treatment of glucocorticoid-induced osteoporosis |
12/09/2014 | US8906857 Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists |
12/09/2014 | US8906856 Single component fibrin hemostat |
12/09/2014 | US8906855 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
12/09/2014 | US8906854 Methods for treating metabolic disorders using FGF |
12/09/2014 | US8906853 [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection |
12/09/2014 | US8906852 Inhibitors of protein tyrosine kinase activity |
12/09/2014 | US8906851 Method for treating diabetes |
12/09/2014 | US8906850 Crystalline insulin-conjugates |
12/09/2014 | US8906849 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
12/09/2014 | US8906848 Aureobasidin derivatives and methods of synthesis |
12/09/2014 | US8906846 Method of treating inflammatory bowel disease by administering a clip-inducing agent |
12/09/2014 | US8906845 Peptide compounds to regulate the complement system |
12/09/2014 | US8906844 Immunomodulatory peptides |
12/09/2014 | US8906681 Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns |
12/09/2014 | US8906679 Composite for thermo-sensitive cell-tissue transplanted scaffold and use thereof |
12/09/2014 | US8906676 Modified human four helical bundle polypeptides and their uses |
12/09/2014 | US8906675 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
12/09/2014 | US8906667 Increasing NADPH-dependent products |
12/09/2014 | US8906662 Compositions and methods for treating inflammatory bowel disease and airway inflammation |
12/09/2014 | US8906661 ADAMTS-13 mutant |
12/09/2014 | US8906648 Recombinant production of vascular endothelial growth factor |
12/09/2014 | US8906640 Methods of measuring protein and/or fat digestibility and uses thereof |
12/09/2014 | US8906637 Methods for detecting targets |
12/09/2014 | US8906444 Diazonium salt modification of silk polymer |
12/09/2014 | US8906425 Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
12/09/2014 | US8906424 Licorice polyphenol preparation |
12/09/2014 | US8906390 Synthetic lipid rafts and methods of use |
12/09/2014 | US8906384 Antiviral activity of bovine type III interferon against foot-and-mouth disease virus |
12/09/2014 | US8906383 T cell receptor having binding affinity for a peptide-MHC complex and uses thereof |
12/09/2014 | US8906380 Fungal immunostimulatory compositions |
12/09/2014 | US8906379 Targeting of glycoprotein therapeutics |
12/09/2014 | US8906378 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
12/09/2014 | US8906377 Stably tethered structures of defined compositions with multiple functions or binding specificities |
12/09/2014 | US8906366 Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same |
12/09/2014 | US8906365 Antimicrobial agents |
12/09/2014 | US8906364 Antimicrobial compositions and uses thereof |
12/09/2014 | US8906363 Fusion proteins for the treatment of CNS |
12/09/2014 | US8906360 Light-activated cation channel and uses thereof |
12/09/2014 | US8906356 Mutant interleukin-2 (IL-2) polypeptides |
12/09/2014 | US8906355 Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof |
12/09/2014 | US8905979 Method of administration of a pulmonary surfactant |
12/09/2014 | US8905913 Method and composition for synchronizing time of insemination |
12/05/2014 | DE202012013134U1 Pharmazeutische Aerosolformulierung von Protease-Inhibitoren und deren Zubereitung A pharmaceutical aerosol formulation of protease inhibitors and their preparation |
12/04/2014 | US20140357855 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
12/04/2014 | US20140357846 Thyroid stimulating hormone compositions |
12/04/2014 | US20140357844 Antibodies specific for trop-2 and their uses |
12/04/2014 | US20140357843 Immunoglobulin fc variants |
12/04/2014 | US20140357842 Yersinia outer protein m (yopm) in the treatment of psoriasis |
12/04/2014 | US20140357698 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
12/04/2014 | US20140357586 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions |
12/04/2014 | US20140357576 Methods for enhancement of muscle protein synthesis |
12/04/2014 | US20140357574 Novel sustained release polymer |
12/04/2014 | US20140357572 Neurotrophic peptides for the treatment of tauopathies |
12/04/2014 | US20140357571 Glutamine enriched nutritional composition for preterm infants |
12/04/2014 | US20140357570 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders |
12/04/2014 | US20140357568 Method of Increasing Muscle Mass and Strength and Compositions Therefor |
12/04/2014 | US20140357566 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands |
12/04/2014 | US20140357563 Compositions and Methods for the Generation of Activated Protein C and Methods of Use Thereof |
12/04/2014 | US20140357562 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
12/04/2014 | US20140357561 Natriuretic polypeptide delivery systems |
12/04/2014 | US20140357560 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week in a unit dose of 100 to 200 units |
12/04/2014 | US20140357557 Cyclodextrin-based polymers for therapeutic delivery |
12/04/2014 | US20140357556 Novel Target for Diagnosis and Treatment of Diabetes and Cardiovascular Diseases |
12/04/2014 | US20140357554 Magnesium Compositions for Modulating the Pharmacokinetics and Injection Site Pain of Insulin |
12/04/2014 | US20140357553 Nutritional composition for wound healing |
12/04/2014 | US20140357551 Organic compounds and their uses |
12/04/2014 | US20140357550 Pharmaceutical Composition for Treatment of Acute Toxic Conditions |
12/04/2014 | US20140357548 Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors |
12/04/2014 | US20140356957 Biological Pacemaker |
12/04/2014 | US20140356814 Dental implant having enhanced early stability and method for manufacturing same |
12/04/2014 | US20140356442 Pharmaceutical compositions of triptorelin microspheres |